Adrenocortical Carcinoma
📧 Sign up to get email alerts when something new happens for Adrenocortical Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-03Clinical Trial Update: Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Malignancies [Phase 1, Phase 2]
A Phase 1/2 trial evaluating the combination of anti-CTLA4-NF mAb (BMS-986218), nivolumab, and stereotactic body radiation therapy for metas…
-
CLINICAL_TRIALS trial_result · 2026-01-30Clinical Trial Update: A Novel Therapeutic Vaccine (EO2401) in Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/Paraganglioma [Phase 1, Phase 2]
Clinical trial update for EO2401 in metastatic adrenocortical carcinoma and malignant pheochromocytoma/paraganglioma reports termination of …
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: A Phase 1 Study of [225Ac]-FPI-1434 Injection [Phase 1]
A Phase 1 study of [225Ac]-FPI-1434 injection sponsored by Fusion Pharmaceuticals has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-12-02Clinical Trial Update: Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI [Phase 2]
Phase 2 trial evaluating dostarlimab for locally advanced or metastatic dMMR/MSI cancers excluding colorectal and endometrial, across multip…
-
CLINICAL_TRIALS trial_result · 2025-10-06Clinical Trial Update: Cemiplimab as Maintenance Treatment for Advanced Adrenocortical Cancer [Phase 2]
A Phase 2 trial is evaluating cemiplimab as maintenance therapy for advanced adrenocortical carcinoma and is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-10-03Clinical Trial Update: Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma [Phase 2]
Phase 2 clinical trial evaluating surgery with heated intraperitoneal chemotherapy for adrenocortical carcinoma with peritoneal carcinomatos…
-
CLINICAL_TRIALS trial_result · 2025-08-26Clinical Trial Update: Evaluation of Side Effects of Mitotane
A clinical trial update on evaluating the side effects of mitotane in patients with adrenocortical carcinoma.
-
CLINICAL_TRIALS trial_result · 2025-06-19Clinical Trial Update: A Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab in Combination With Mitotane in Patients With Advanced Adrenocortical Carcinoma [Phase 2]
Phase II study evaluating pembrolizumab in combination with mitotane for advanced adrenocortical carcinoma has been terminated, with results…
-
CLINICAL_TRIALS trial_result · 2024-12-10Clinical Trial Update: Cabozantinib in Treating Patients With Locally Advanced or Metastatic Unresectable Adrenocortical Carcinoma [Phase 2]
A Phase 2 trial of cabozantinib in locally advanced or metastatic unresectable adrenocortical carcinoma has completed and results were poste…
-
CLINICAL_TRIALS trial_result · 2024-12-09Clinical Trial Update: Phase 1 Study of 68Ga-R8760 [Phase 1]
The Phase 1 trial of the radiopharmaceutical 68Ga-R8760 for adrenocortical carcinoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-11-20Clinical Trial Update: A Study of OSI-906 in Patients With Locally Advanced or Metastatic Adrenocortical Carcinoma [Phase 3]
This is an update on a Phase 3 trial evaluating OSI-906 (linsitinib) in locally advanced or metastatic adrenocortical carcinoma. The study h…
-
CLINICAL_TRIALS trial_result · 2024-08-19Clinical Trial Update: Cabozantinib in Advanced Adrenocortical Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating cabozantinib for advanced adrenocortical carcinoma is ongoing, with no results or status information pro…
-
CLINICAL_TRIALS trial_result · 2024-08-01Clinical Trial Update: Adjuvant Chemotherapy vs. Observation/Mitotane After Primary Surgical Resection of Localized Adrenocortical CarcInoma [Phase 3]
Phase 3 trial comparing adjuvant chemotherapy versus observation with mitotane after surgical resection of localized adrenocortical carcinom…
-
CLINICAL_TRIALS trial_result · 2024-06-18Clinical Trial Update: Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic [Phase 2]
Phase 2 study of pembrolizumab in patients with rare, unresectable or metastatic solid tumors; results have been posted.
-
CLINICAL_TRIALS trial_result · 2020-01-06Clinical Trial Update: Single Agent Pembrolizumab in Subjects With Advanced Adrenocortical Carcinoma [Phase 2]
Phase 2 trial evaluating pembrolizumab as a single agent in advanced adrenocortical carcinoma has posted results. The study status is active…
-
CLINICAL_TRIALS trial_result · 2019-07-30Clinical Trial Update: Surgery and Heated Chemotherapy for Adrenocortical Carcinoma [Phase 2]
Phase 2 trial evaluating surgery with heated chemotherapy for adrenocortical carcinoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-05-01Clinical Trial Update: Nivolumab in Treating Patients With Metastatic Adrenocortical Cancer [Phase 2]
Phase 2 clinical trial of nivolumab in metastatic/adrenal cortex carcinoma (adrenocortical cancer) has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2019-01-31Clinical Trial Update: Sunitinib in Refractory Adrenocortical Carcinoma [Phase 2]
A Phase 2 trial of sunitinib in patients with refractory adrenocortical carcinoma has completed, with results posted in January 2019.
-
CLINICAL_TRIALS trial_result · 2019-01-16Clinical Trial Update: A Dose Finding Study of TKM-080301 Infusion in Neuroendocrine Tumors (NET) and Adrenocortical Carcinoma (ACC) Patients [Phase 1, Phase 2]
Phase 1/2 dose-finding study of TKM-080301 infusion in neuroendocrine tumors and adrenocortical carcinoma has been completed.
-
CLINICAL_TRIALS trial_result · 2018-05-17Clinical Trial Update: Phase II Trial of ZD1839 (Iressa) in Patients With Nonresectable Adrenocortical Carcinoma (ACC) [Phase 2]
A Phase II study evaluating ZD1839 (Iressa) in patients with nonresectable adrenocortical carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2018-05-09Clinical Trial Update: Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer [Phase 2]
Phase 2 trial of antineoplaston therapy for Stage IV adrenocortical carcinoma was terminated; results were posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-04-11Clinical Trial Update: Cabazitaxel Activity in Patients With Advanced AdrenoCortical-Carcinoma Progressing After Previous Chemotherapy Lines [Phase 2]
Phase 2 trial evaluating cabazitaxel in patients with advanced adrenocortical carcinoma progressing after prior chemotherapy shows activity.…
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma [Phase 1]
This update reports the completion of a Phase 1 study of ATR-101 in adults with advanced Adrenocortical Carcinoma.
-
CLINICAL_TRIALS trial_result · 2017-05-08Clinical Trial Update: Efficacy of Adjuvant Mitotane Treatment (ADIUVO) [Phase 3]
Phase 3 trial ADIUVO evaluating adjuvant mitotane for adrenocortical carcinoma; the update notes the trial status as UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2017-04-25Clinical Trial Update: Clinical Trial of Dovitinib in First-line Metastatic or Locally Advanced Non-resectable Adrenocortical Carcinoma [Phase 2]
A Phase 2 trial of dovitinib as first-line treatment for metastatic or locally advanced non-resectable adrenocortical carcinoma has complete…